Runway Growth Finance (RWAY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
The annual meeting will be held virtually on June 23, 2026, for shareholders of record as of April 24, 2026.
Shareholders will vote on electing two Class I directors and ratifying Deloitte & Touche LLP as the independent auditor for 2026.
Proxy materials are available online, with options for electronic or mail voting to streamline participation and reduce costs.
The Board unanimously recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Proposals include electing two Class I directors for three-year terms and ratifying Deloitte & Touche LLP as auditor.
Shareholders may also act on other business properly brought before the meeting.
Voting can be done online, by phone, mail, or virtually at the meeting; a majority quorum is required.
Stockholder proposals for the 2027 meeting must be submitted by January 5, 2027, for proxy inclusion.
Board of directors and corporate governance
The Board consists of eight members divided into three staggered classes, with six independent directors.
Independent directors meet Nasdaq and 1940 Act standards; regular executive sessions are held without interested directors.
The Board has Audit, Nominating and Corporate Governance, and Compensation Committees, all composed solely of independent directors.
The Chairman is an interested director, but governance policies are in place to mitigate conflicts.
Latest events from Runway Growth Finance
- Shareholders will vote on two director nominees and auditor ratification at the June 2026 virtual meeting.RWAY
Proxy filing29 Apr 2026 - Lower Q4 2025 income, strong portfolio, and SWK deal to drive future growth.RWAY
Q4 202512 Mar 2026 - Q2 2024 featured strong new investments, robust yields, and active capital return programs.RWAY
Q2 20241 Feb 2026 - Q3 2024 saw $75.3M in new loans, strong yields, and a strategic adviser acquisition pending.RWAY
Q3 202414 Jan 2026 - $220M NAV-for-NAV merger boosts healthcare exposure and scale, closing by early 2026.RWAY
M&A Announcement7 Jan 2026 - NAV per share rose to $13.79 in 2024, with strong yields and expanded growth capacity.RWAY
Q4 202425 Dec 2025 - Vote sought on new advisory agreement, director election, and adjournment; no fee or strategy changes.RWAY
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections and auditor ratification at the 2024 virtual meeting.RWAY
Proxy Filing2 Dec 2025 - Shareholders to vote on a new advisory agreement after Adviser change in control, with no fee changes.RWAY
Proxy Filing2 Dec 2025